Analysis of inhaled corticosteroid selection in patients with bronchial asthma using a questionnaire survey - Effects of age, gender, and disease severity

Allergology International

Volumn 58, Issue 3, 2009, Pages 365-371

  Ota, Kyuma ^a   Hasegawa, Takashi ^b   Koya, Toshiyuki ^a   Sakagami, Takuro ^a   Sekikawa, Takashi ^a   Toyabe, Shinichi ^b   Akazawa, Kohei ^b   Arakawa, Masaaki ^a   Gejyo, Fumitake ^a   Suzuki, Eiichi ^b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Bronchial asthma; Inhaled corticosteroid; Japan; Selection strategy; Therapy

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; FLUORINATED HYDROCARBON; FLUTICASONE PROPIONATE; SALMETEROL; THEOPHYLLINE; TULOBUTEROL;

ABSENTEEISM; ADULT; AGE; ARTICLE; ASTHMA; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG INDICATION; DRY POWDER; FEMALE; HUMAN; INDIVIDUALIZATION; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; METERED DOSE INHALER; PATIENT CARE; PEAK EXPIRATORY FLOW; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; SMOKING CESSATION;

EID: 70450184779     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.08-OA-0077     Document Type: Article

References (20)

1. Mattoli S, Mattoso VL, Soloperto M, Allegra L, Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J Allergy Clin Immunol 1991;87:794-802.
2. Bentley AM, Menz G, Storz C et al. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Am Rev Respir Dis 1992;146:500-506
3. National Asthma Education and Prevention Program: Guidelines for the Diagnosis and Management of Asthma. Update on Selected Topics 2002. Bethesda: National Institute of Health, 2002.
4. Asthma prevention and management guidelines. Ministry of Health and Welfare, Japan. Int Arch Allergy Immunol 2000;121(Suppl 1):I-VIII, 1-77.
5. Guidelines for the management of asthma: a summary. British Thoracic Society and others. BMJ 1993;306:776-782
6. Hasegawa T, Suzuki E, Terada M et al. Improvement of asthma management in actual practice consistent with prevalence of anti-inflammatory agents. Based on questionnaire surveys in Niigata Prefecture, Japan from 1998 to 2002. Allergol Int 2005;54:555-563
7. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben- Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest 2000;117:542-550 (Pubitemid 30111609)
8. Hasegawa T, Suzuki E, Koya T et al. Analysis of drug compliance in adult patients with bronchial asthma. Based on questionnaire surveys in Niigata Prefecture, Japan. General Medicine 2004;5:7-12.
9. McAllister J. An overview of the current asthma disease management guidance. Br J Nurs 2004;13:512-517
10. Suzuki E, Hasegawa T, Koya T et al. Questionnaire-based analysis of current status of adult bronchial asthma in Niigata Prefecture. Comparison with the asthma guideline. Acta Med Biol 2002;50:135-143 (Pubitemid 35332263)
11. Suzuki E, Hasegawa T, Koya T et al. Questionnaire-based characterization of bronchial asthma in elderly. Analysis in Niigata Prefecture, Japan. Allergol Int 2002;51:241-248 (Pubitemid 36139162)
12. Yoshimine F, Hasegawa T, Suzuki E et al. Contribution of aspirin intolerant asthma to near fatal asthma based on questionnaire surveys in Niigata Prefecture, Japan. Respirology 2005;10:477-484 (Pubitemid 43942617)
13. Satoh H, Hasegawa T, Suzuki E et al. Gender differences in susceptibility of asthma to active smoking. Questionnaire based analysis in the Niigata Prefecture, Japan. Allergol Int 2005;54:401-410 (Pubitemid 41355206)
14. Hasegawa T, Suzuki E, Muramatsu Y et al. Questionnaire-based analysis of the current level of asthma control and management in Niigata Prefecture, Japan: Changes from 1998 to 2000. Allergol Int 2004;53:135-144
15. Hasegawa T, Suzuki E, Terada M et al. Improvement of asthma management in actual practice consistent with prevalence of anti-inflammatory agents. Based on questionnaire surveys in Niigata Prefecture, Japan from 1998 to 2002. Allergol Int 2005;54:555-563
16. Blais L, Beauchesne MF, Rey E, Malo JL, Forget A. Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma. Thorax 2007;62:320-328 (Pubitemid 46580575)
17. Osur SL. The management of asthma and rhinitis during pregnancy. J Womens Health (Larchmt) 2005;14:263-276
18. Agertoft L, Pedersen S. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. J Allergy Clin Immunol 1997;99:773-780 (Pubitemid 27280368)
19. Thorsson L, Geller D. Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide. Respir Med 2005;99:836-849 (Pubitemid 40796558)
20. Rau JL. Practical problems with aerosol therapy in COPD. Respir Care 2006;51:158-172